🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Since measles-mumps-rubella (MMR) and varicella vaccinations are establishe...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04
Trial ID
NCT00352898
Treatments Being Tested
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Investigational Site Number : 0560004
Start Date
2025-05-22
Trial ID
NCT06975878
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
The purpose of this observer blinded study is to provide information on vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-20
Trial ID
NCT00578175
Treatments Being Tested
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-07
Trial ID
NCT02062502
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
This phase 3b study will compare the immunogenicity and reactogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-01
Trial ID
NCT00871000
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-10-06
Trial ID
NCT00197015